Patents by Inventor Anthony D. Sandler

Anthony D. Sandler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931465
    Abstract: Combination treatment with Prussian blue nanoparticles and at least one immunotherapeutic treatment. Stable, functionalized Prussian blue nanoparticles, including those with enhanced stability under alkaline conditions, and methods of cancer, neoplasm, and tumor treatment using them, including photothermal treatment and combination immunotherapeutic treatments.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: March 19, 2024
    Assignee: Children's National Medical Center
    Inventors: Rohan Fernandes, Raymond W. Sze, Conrad Russell Y. Cruz, Anthony D. Sandler, Catherine M. Bollard, Elizabeth E. Sweeney, Juliana Cano-Mejia, Rachel Burga, Matthieu F. Dumont
  • Publication number: 20200163899
    Abstract: Combination treatment with Prussian blue nanoparticles and at least one immunotherapeutic treatment. Stable, functionalized Prussian blue nanoparticles, including those with enhanced stability under alkaline conditions, and methods of cancer, neoplasm, and tumor treatment using them, including photothermal treatment and combination immunotherapeutic treatments.
    Type: Application
    Filed: March 8, 2017
    Publication date: May 28, 2020
    Applicant: Children's National Medical Center
    Inventors: Rohan FERNANDES, Raymond W. SZE, Conrad Russell Y. CRUZ, Anthony D. SANDLER, Catherine M. BOLLARD, Elizabeth E. SWEENEY, Juliana CANO-MEJIA, Rachel BURGA, Mathieu F. DUMONT
  • Publication number: 20140358150
    Abstract: A surgical distraction apparatus is disclosed. The surgical distraction apparatus includes a tissue distraction device adapted for implantation, the tissue distraction device including a plurality of distraction members, one or more actuators adapted for implantation and operatively coupled to the tissue distraction device, the one or more actuators being configured to drive the tissue distraction device and adjust the alignment of the plurality of distraction members, and an activator adapted to deliver one or more pulses to at least one actuator in the one or more actuators.
    Type: Application
    Filed: May 28, 2014
    Publication date: December 4, 2014
    Applicant: Children's National Medical Center
    Inventors: Roger E. Kaufman, Anthony D. Sandler
  • Patent number: 7238492
    Abstract: The present invention provides methods and kits for predicting recurrence of tumor or cancer in a mammal by calculating the ratio of the amount of Survivin to the amount of pro-apoptosis factor (PAF) in a physiological sample.
    Type: Grant
    Filed: September 22, 2003
    Date of Patent: July 3, 2007
    Assignee: University of Iowa Research Foundation
    Inventor: Anthony D. Sandler
  • Publication number: 20040137540
    Abstract: The present invention provides methods and kits for predicting recurrence of tumor or cancer in a mammal by calculating the ratio of the amount of Survivin and the amount of PAF in a physiological sample.
    Type: Application
    Filed: September 22, 2003
    Publication date: July 15, 2004
    Inventor: Anthony D. Sandler
  • Patent number: 6656684
    Abstract: The present invention provides methods and kits for predicting recurrence of tumor or cancer in a mammal by calculating the ratio of the amount of Survivin and the amount of PAF in a physiological sample.
    Type: Grant
    Filed: November 2, 2000
    Date of Patent: December 2, 2003
    Assignee: University of Iowa Research Foundation
    Inventor: Anthony D. Sandler